.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
US Army
Argus Health
Daiichi Sankyo
Federal Trade Commission
Boehringer Ingelheim
Cerilliant
Mallinckrodt
Novartis

Generated: February 17, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0525680.5

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpY
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpY
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpY
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpY
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpY
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpY
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpY
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpY
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpUSE OF INGENOL MEBUTATE TO TREAT ACTINIC KERATOSIS
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes➤ Sign Up➤ Sign UpUSE OF INGENOL MEBUTATE TO TREAT ACTINIC KERATOSIS
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist